or
forgot password
  • cancer clinical trials in oklahoma city, OK

  • Biomarkers in Patients With Previously Untreated Invasive Ovarian Epithelial, Fallopian Tube, or Peritoneal Cancer
    Oklahoma University Cancer Institute
    Oklahoma City, Oklahoma 73104
    Fallopian Tube Cancer, Ovarian Cancer, Primary Peritoneal Cavity Cancer
    Study of US-ATG-F to Prevent Chronic Graft Versus Host Disease (GVHD)
    University of Oklahoma Health Sciences Center
    Oklahoma City, Oklahoma 73104
    GVHD, Adult Acute Myeloid Leukemia, Adult Acute Lymphoid Leukemia, Myelodysplastic Syndrome
    Safety Study of X-82 in Patients With Advanced Solid Tumors
    Peggy and Charles Stephens Oklahoma Cancer Center
    Oklahoma City, Oklahoma 73104
    Advanced Solid Tumors
    Safety and Efficacy of BKM120 in Patients With Metastatic Non-small Cell Lung Cancer
    University of Oklahoma Health Sciences Center Dept. of Oklahoma Univ. HSC
    Oklahoma City, Oklahoma 73104
    Non-small Cell Lung Cancer
    A 12 Week Study to Confirm the Effectiveness of 8mg of Fesoterodine Compared to 4mg of Fesoterodine
    Lynn Health Science Institute

    Trial Locations
    Lynn Health Science Institute
    Legacy Clinical Research, LLC
    Overactive Bladder
    Caspofungin Acetate or Fluconazole in Preventing Invasive Fungal Infections in Patients With Acute Myeloid Leukemia Who Are Undergoing Chemotherapy
    Oklahoma University Cancer Institute
    Oklahoma City, Oklahoma 73104
    Fungal Infection, Leukemia, Neutropenia
    E7050 in Combination With Cetuximab Versus Cetuximab Alone in the Treatment of Platinum-Resistant Squamous Cell Carcinoma of the Head and Neck
    Peggy & Charles Stephenson Oklahoma Cancer Ctr
    Oklahoma City, Oklahoma 73104
    Platinum-Resistant Squamous Cell Carcinoma of the Head and Neck
    PET Scan Imaging in Assessing Response in Patients With Esophageal Cancer Receiving Combination Chemotherapy
    Oklahoma University Cancer Institute
    Oklahoma City, Oklahoma 73104
    Adenocarcinoma of the Gastroesophageal Junction, Esophageal Cancer
    Biological Therapy, Sargramostim, and Isotretinoin in Treating Patients With Relapsed or Refractory Neuroblastoma
    University of Oklahoma Health Sciences Center
    Oklahoma City, Oklahoma 73104
    Recurrent Neuroblastoma
    Pilot Study of Lupron to Improve Immune Function After Allogeneic Bone Marrow Transplantation
    University of Oklahoma
    Oklahoma City, Oklahoma 73190
    Acute Lymphocytic Leukemia, Acute Myelogenous Leukemia, Myelodysplastic Syndrome RAEB 1
    Reduced Intensity Conditioning Versus Myeloablative Conditioning for Acute Myeloid Leukemia or Myelodysplastic Syndrome (BMT CTN 0901)
    University of Oklahoma Medical Center
    Oklahoma City, Oklahoma 73104
    Leukemia, Myelocytic, Acute
    A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
    University of Oklahoma Health Science Center
    Oklahoma City, Oklahoma 73104
    Hematological Malignancies, Certain Lysosomal Storage and Peroxisomal Enzyme Deficiency Disorders, Hurler Syndrome (MPS I), Krabbe Disease (Globoid Leukodystrophy), X-linked Adrenoleukodystrophy, Primary Immunodeficiency Diseases, Bone Marrow Failure, Beta-thalassemia
    FOLFIRINOX in Patients With Inoperable Pancreatic Cancer
    University of Oklahoma Health Sciences Center
    Oklahoma City, Oklahoma 73104
    Adenocarcinoma of Pancreas
    National Marrow Donor Program Long-Term Donor Follow-Up
    Oklahoma Blood Institute
    Oklahoma City, Oklahoma 73104-3251
    Hematologic Neoplasms
    Chemotherapy Toxicity On Quality of Life in Older Patients With Stage I, Stage II, Stage III, or Stage IV Ovarian Epithelial, Primary Peritoneal Cavity, or Fallopian Tube Cancer
    Oklahoma University Cancer Institute
    Oklahoma City, Oklahoma 73104
    Fallopian Tube Cancer, Ovarian Cancer, Primary Peritoneal Cavity Cancer
    Androgen-Deprivation Therapy and Radiation Therapy in Treating Patients With Prostate Cancer
    Oklahoma University Cancer Institute
    Oklahoma City, Oklahoma 73104
    Prostate Cancer
    Long-Term Safety of Twice Daily Oxycodone Hydrochloride Controlled-release Tablets in Children Who Completed OTR3001
    Lynn Health Sciences Institute

    Trial Locations
    Lynn Health Sciences Institute
    The Children's Hospital at Oklahoma University Medical Center
    Pain
    Quality of Life and Care Needs of Patients With Persistent or Recurrent Ovarian Cancer, Fallopian Tube Cancer, or Peritoneal Cancer
    Oklahoma University Cancer Institute
    Oklahoma City, Oklahoma 73104
    Anxiety Disorder, Fallopian Tube Cancer, Fatigue, Nausea and Vomiting, Neurotoxicity, Ovarian Cancer, Primary Peritoneal Cavity Cancer
    Modafinil in Treating Children With Memory and Attention Problems Caused by Cancer Treatment for a Brain Tumor
    University of Oklahoma Health Sciences Center
    Oklahoma City, Oklahoma 73104
    Brain and Central Nervous System Tumors, Cognitive/Functional Effects, Fatigue, Neurotoxicity, Psychosocial Effects of Cancer and Its Treatment
    Temsirolimus, Dexamethasone, Mitoxantrone Hydrochloride, Vincristine Sulfate, and Pegaspargase in Treating Young Patients With Relapsed Acute Lymphoblastic Leukemia or Non-Hodgkin Lymphoma
    University of Oklahoma Health Sciences Center
    Oklahoma City, Oklahoma 73104
    B-cell Childhood Acute Lymphoblastic Leukemia, Peripheral T-cell Lymphoma, Recurrent Childhood Acute Lymphoblastic Leukemia, Recurrent Childhood Lymphoblastic Lymphoma, T-cell Childhood Acute Lymphoblastic Leukemia
    Combination Chemotherapy in Treating Young Patients With Newly Diagnosed High-Risk Acute Lymphoblastic Leukemia
    University of Oklahoma Health Sciences Center
    Oklahoma City, Oklahoma 73104
    B-cell Adult Acute Lymphoblastic Leukemia, B-cell Childhood Acute Lymphoblastic Leukemia, Cognitive/Functional Effects, Neurotoxicity, Pain, Philadelphia Chromosome Positive Childhood Precursor Acute Lymphoblastic Leukemia, Therapy-related Toxicity, Untreated Adult Acute Lymphoblastic Leukemia, Untreated Childhood Acute Lymphoblastic Leukemia
    Cisplatin and Radiation Therapy With or Without Carboplatin and Paclitaxel in Patients With Locally Advanced Cervical Cancer
    Oklahoma University Cancer Institute
    Oklahoma City, Oklahoma 73104
    Cervical Cancer, Chemotherapeutic Agent Toxicity, Cognitive/Functional Effects, Psychosocial Effects of Cancer and Its Treatment, Radiation Toxicity, Sexuality and Reproductive Issues
    Natural History of Brain Function, Quality of Life, and Seizure Control in Patients With Brain Tumor Who Have Undergone Surgery
    University of Oklahoma Health Sciences Center
    Oklahoma City, Oklahoma 73104
    Adult Diffuse Astrocytoma, Adult Mixed Glioma, Adult Oligodendroglioma, Cognitive/Functional Effects, Neurotoxicity, Psychosocial Effects of Cancer and Its Treatment, Seizure
    Decitabine With or Without Bortezomib in Treating Older Patients With Acute Myeloid Leukemia
    Cancer Care Associates-Mercy
    Oklahoma City, Oklahoma 73120
    Acute Myeloid Leukemia With Multilineage Dysplasia Following Myelodysplastic Syndrome, Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, Adult Acute Myeloid Leukemia With Del(5q), Adult Acute Myeloid Leukemia With t(16;16)(p13;q22), Secondary Acute Myeloid Leukemia, Untreated Adult Acute Myeloid Leukemia
    Bioequivalence of 2 Formulations of TKI258 in Patients With Advanced Solid Tumors
    University of Oklahoma Health Sciences Center OUHSC - SC
    Oklahoma City, Oklahoma 73104
    Advanced Solid Tumors, Excluding Breast Cancer
    Radiation Therapy in Treating Patients With Prostate Cancer
    Oklahoma University Cancer Institute
    Oklahoma City, Oklahoma 73104
    Prostate Cancer, Psychosocial Effects of Cancer and Its Treatment, Radiation Toxicity, Sexual Dysfunction
    Veliparib, Doxorubicin Hydrochloride, Carboplatin, and Bevacizumab in Treating Patients With Recurrent Ovarian Cancer, Primary Peritoneal Cancer, or Fallopian Tube Cancer
    University of Oklahoma Health Sciences Center
    Oklahoma City, Oklahoma 73104
    Ovarian Clear Cell Cystadenocarcinoma, Ovarian Endometrioid Adenocarcinoma, Ovarian Mixed Epithelial Carcinoma, Ovarian Serous Cystadenocarcinoma, Ovarian Undifferentiated Adenocarcinoma, Recurrent Fallopian Tube Cancer, Recurrent Ovarian Epithelial Cancer, Recurrent Primary Peritoneal Cavity Cancer
    Pediatric Philadelphia Positive Acute Lymphoblastic Leukemia
    University of Oklahoma Health Sciences Center
    Oklahoma City, Oklahoma 73104
    Leukemia, Pediatric
    Sunitinib Malate in Treating Younger Patients With Recurrent, Refractory, or Progressive Malignant Glioma or Ependymoma
    University of Oklahoma Health Sciences Center
    Oklahoma City, Oklahoma 73104
    Childhood Cerebral Astrocytoma/Malignant Glioma, Childhood High-grade Cerebellar Astrocytoma, Childhood High-grade Cerebral Astrocytoma, Childhood Infratentorial Ependymoma, Childhood Mixed Glioma, Childhood Oligodendroglioma, Childhood Supratentorial Ependymoma, Recurrent Childhood Cerebellar Astrocytoma, Recurrent Childhood Cerebral Astrocytoma, Recurrent Childhood Ependymoma, Recurrent Childhood Subependymal Giant Cell Astrocytoma
    Paclitaxel With or Without Pazopanib Hydrochloride in Treating Patients With Persistent or Recurrent Ovarian Epithelial, Fallopian Tube, or Peritoneal Cavity Cancer
    University of Oklahoma Health Sciences Center
    Oklahoma City, Oklahoma 73104
    Recurrent Fallopian Tube Cancer, Recurrent Ovarian Epithelial Cancer, Recurrent Primary Peritoneal Cavity Cancer
    A Multicenter "Ablate and Resect" Study of Novilase® Interstitial Laser Therapy for the Ablation of Small Breast Cancers
    University of Oklahoma Health Sciences Center
    Oklahoma City, Oklahoma 73104
    Malignant Tumor
    EGEN-001 and Pegylated Liposomal Doxorubicin Hydrochloride in Patients With Recurrent or Persistent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer
    University of Oklahoma Health Sciences Center
    Oklahoma City, Oklahoma 73104
    Fallopian Tube Cancer, Ovarian Cancer, Primary Peritoneal Cavity Cancer
    Observation in Patients With Early-Stage Vulvar Cancer Following Surgery and/or Radiation Therapy
    Oklahoma University Cancer Institute
    Oklahoma City, Oklahoma 73104
    Long-term Effects Secondary to Cancer Therapy in Adults, Vulvar Cancer
    Sorafenib Tosylate in Treating Younger Patients With Relapsed or Refractory Rhabdomyosarcoma, Wilms Tumor, Liver Cancer, or Thyroid Cancer
    University of Oklahoma Health Sciences Center
    Oklahoma City, Oklahoma 73104
    Childhood Hepatocellular Carcinoma, Papillary Thyroid Cancer, Previously Treated Childhood Rhabdomyosarcoma, Recurrent Childhood Liver Cancer, Recurrent Childhood Rhabdomyosarcoma, Recurrent Thyroid Cancer, Recurrent Wilms Tumor and Other Childhood Kidney Tumors
    Azacitidine With or Without Lenalidomide or Vorinostat in Patients With Higher-Risk Myelodysplastic Syndromes or Chronic Myelomonocytic Leukemia
    University of Oklahoma Health Sciences Center

    Trial Locations
    University of Oklahoma Health Sciences Center
    Cancer Care Associates-Mercy
    Chronic Myelomonocytic Leukemia, de Novo Myelodysplastic Syndromes, Previously Treated Myelodysplastic Syndromes, Refractory Anemia With Excess Blasts, Secondary Myelodysplastic Syndromes
    Methotrexate or Dactinomycin in Treating Patients With Low-Risk Gestational Trophoblastic Neoplasia
    Oklahoma University Cancer Institute
    Oklahoma City, Oklahoma 73104
    Gestational Trophoblastic Tumor
    Veliparib in Treating Patients With Persistent or Recurrent Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
    University of Oklahoma Health Sciences Center
    Oklahoma City, Oklahoma 73104
    BRCA1 Mutation Carrier, BRCA2 Mutation Carrier, Recurrent Fallopian Tube Cancer, Recurrent Ovarian Epithelial Cancer, Recurrent Primary Peritoneal Cavity Cancer
    Docetaxel and Cyclophosphamide Compared to Anthracycline-Based Chemotherapy in Treating Women With HER2-Negative Breast Cancer
    University of Oklahoma Health Sciences Center

    Trial Locations
    University of Oklahoma Health Sciences Center
    Cancer Care Associates-Mercy
    Breast Cancer
    Pazopanib Hydrochloride in Treating Patients With Metastatic Kidney Cancer Who Have No Evidence of Disease After Surgery
    Cancer Care Associates-Mercy
    Oklahoma City, Oklahoma 73120
    Clear Cell Renal Cell Carcinoma, Stage IV Renal Cell Cancer
    Phase 3 Trial of Autologous Dendritic Cell Immunotherapy (AGS-003) Plus Standard Treatment of Advanced Renal Cell Carcinoma (RCC)
    University of Oklahoma Health Sciences Center
    Oklahoma City, Oklahoma 73104
    Advanced Renal Cell Carcinoma, Renal Cell Carcinoma, Metastatic Renal Cell Carcinoma
    Study to Assess Food Effect on Pharmacokinetics of Entinostat in Subjects With Breast Cancer or Non-Small Cell Lung Cancer
    Peggy and Charles Stephenson Cancer Center
    Oklahoma City, Oklahoma 73104
    Lung Cancer, Non Small Cell Lung Cancer (NSCLC), Breast Cancer, ER+ Breast Cancer
    Combination Chemotherapy With or Without Rituximab in Treating Younger Patients With Stage III-IV Non-Hodgkin Lymphoma or B-Cell Acute Leukemia
    University of Oklahoma Health Sciences Center
    Oklahoma City, Oklahoma 73104
    B-cell Childhood Acute Lymphoblastic Leukemia, Childhood Diffuse Large Cell Lymphoma, L3 Childhood Acute Lymphoblastic Leukemia, Stage III Childhood Large Cell Lymphoma, Stage IV Childhood Large Cell Lymphoma, Untreated Childhood Acute Lymphoblastic Leukemia
    Chemotherapy Followed by Radiation Therapy in Treating Younger Patients With Newly Diagnosed Localized Central Nervous System Germ Cell Tumors
    University of Oklahoma Health Sciences Center
    Oklahoma City, Oklahoma 73104
    Childhood Central Nervous System Choriocarcinoma, Childhood Central Nervous System Embryonal Tumor, Childhood Central Nervous System Germ Cell Tumor, Childhood Central Nervous System Germinoma, Childhood Central Nervous System Mixed Germ Cell Tumor, Childhood Central Nervous System Teratoma, Childhood Central Nervous System Yolk Sac Tumor, Childhood Pineal Parenchymal Tumor
    External Beam Radiation With or Without Chemotherapy to Treat High Risk Prostate Cancer
    ProCure Proton Therapy Center
    Oklahoma City, Oklahoma 73142
    Prostate Cancer
    Bevacizumab With or Without Trebananib in Treating Patients With Recurrent Brain Tumor
    University of Oklahoma Health Sciences Center
    Oklahoma City, Oklahoma 73104
    Adult Anaplastic Oligodendroglioma, Adult Giant Cell Glioblastoma, Adult Glioblastoma, Adult Gliosarcoma, Adult Oligodendroglioma, Recurrent Adult Brain Tumor
    Phase II Study of Ipilimumab Monotherapy in Recurrent Platinum Sensitive Ovarian Cancer Patients
    University Of Oklahoma Peggy & Charles Stephenson Cancer Center
    Oklahoma City, Oklahoma 73104
    Ovarian Cancer
    Sorafenib Tosylate Following a Liver Transplant in Treating Patients With Liver Cancer
    Integris-Baptist Medical
    Oklahoma City, Oklahoma 73112
    Adult Primary Hepatocellular Carcinoma, Localized Resectable Adult Primary Liver Cancer, Localized Unresectable Adult Primary Liver Cancer, Recurrent Adult Primary Liver Cancer
    Alisertib in Treating Patients With Recurrent or Persistent Leiomyosarcoma of the Uterus
    University of Oklahoma Health Sciences Center
    Oklahoma City, Oklahoma 73104
    Recurrent Uterine Sarcoma, Uterine Leiomyosarcoma
    Dalantercept in Treating Patients With Recurrent or Persistent Endometrial Cancer
    Oklahoma University Cancer Institute
    Oklahoma City, Oklahoma 73104
    Endometrial Cancer
    Studying the Physical Function and Quality of Life Before and After Surgery in Patients With Stage I Cervical Cancer
    University of Oklahoma Health Sciences Center
    Oklahoma City, Oklahoma 73104
    Cervical Cancer, Lymphedema, Sexuality and Reproductive Issues
    Ponatinib in Newly Diagnosed Chronic Myeloid Leukemia (CML) (EPIC)
    University of Oklahoma, Site #028
    Oklahoma City, Oklahoma 73104
    Chronic Myeloid Leukemia
    Alisertib in Treating Patients With Advanced or Metastatic Sarcoma
    University of Oklahoma Health Sciences Center
    Oklahoma City, Oklahoma 73104
    Adult Alveolar Soft-part Sarcoma, Adult Angiosarcoma, Adult Epithelioid Sarcoma, Adult Extraskeletal Chondrosarcoma, Adult Fibrosarcoma, Adult Leiomyosarcoma, Adult Liposarcoma, Adult Neurofibrosarcoma, Chondrosarcoma, Endometrial Stromal Sarcoma, Mast Cell Sarcoma, Metastatic Adult Malignant Fibrous Histiocytoma of Bone, Ovarian Carcinosarcoma, Ovarian Sarcoma, Recurrent Adult Malignant Fibrous Histiocytoma of Bone, Recurrent Adult Soft Tissue Sarcoma, Small Intestine Leiomyosarcoma, Stage III Adult Soft Tissue Sarcoma, Stage IV Adult Soft Tissue Sarcoma